Retraction
NR2F1-AS1 Acts as an Oncogene in Breast Cancer by Competitively Binding with miR-641
Paper Information
Record ID:
48382
Author(s):
Journal:
Publication Date:
January 17, 2022
Retraction Date:
September 20, 2023
(2.2 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (6)
6
Total Citations2
Post-Retraction(33.3%)
3
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
0
After 2+ years
180
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
PTEN decreases NR2F1 expression to inhibit ciliogenesis during EGFRL858R-induced lung cancer progression
T. Tran, Jan‐Jong Hung
Cell Death and Disease
Open Access
Published: Mar 2024
1 citation
1 citation
180 days after retraction
LncRNA NR2F1-AS1 as a potential biomarker for prognosis in cancer patients: meta and bioinformatics analysis
Lu Tang, Qingmei Liu, Shuang Zhang et al. (4 authors)
Expert Review of Molecular Diagnostics
Published: Oct 2023
1 citation
1 citation
40 days after retraction
Lnc NR2F1-AS1 Promotes Breast Cancer Metastasis by Targeting the MiR-25-3p/ZEB2 Axis
Duanyang Zhai, Yu Zhou, Xiaying Kuang et al. (8 authors)
International Journal of Medical Sciences
Open Access
Published: Jan 2023
6 citations
6 citations
262 days before retraction
Retracted: NR2F1-AS1 Acts as an Oncogene in Breast Cancer by Competitively Binding with miR-641
Journal of Healthcare Engineering
Journal of Healthcare Engineering
Open Access
Published: Jan 2023
262 days before retraction
A review on the role of NR2F1-AS1 in the development of cancer
Soudeh Ghafouri‐Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen et al. (6 authors)
Pathology - Research and Practice
Open Access
Published: Nov 2022
3 citations
3 citations
315 days before retraction
Quick Stats
Total Citations:
10
Years Since Retraction:
2.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025